GENOR-B (06998.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.

Gelonghui, on March 18, announced that GENOR-B (06998.HK) will hold a Board of Directors meeting on March 28, 2025 (Friday), to consider and approve the full year performance of the company and its subsidiaries for the year ending December 31, 2024, and its release.

Gelonghui FinanceMar 18 05:19 ET

GENOR-B: DATE OF BOARD MEETING

HKEXMar 18 05:00 ET · Announcements

Express News | Genor Biopharma - Co and Target Are in Course of Preparing New Listing Application

ReutersFeb 25 04:54 ET

The "DeepSeek Moment" of medicine, has China’s Innovative Drugs also reached it?

Over the past four years, China's share of Global large-scale pharmaceutical Trade has surged from 5% to 30%. From research and development innovation to international mergers and acquisitions, Chinese Innovative Drugs companies are reshaping the Global pharmaceutical innovation landscape.

wallstreetcnFeb 7 20:59 ET

Genor Biopharma Holdings Postpones EGM to February 19

MT NewswiresFeb 4 02:50 ET

Genor Biopharma Proposes to Replace Auditor

MT NewswiresFeb 3 22:56 ET